Clinical Trials
16 trialsNCT00617799 2023-10-10
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
Completed
NCT00806650 2017-12-08
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
City of Hope Medical Center
Completed
NCT00666978 2017-11-13
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
University of Kansas Medical Center
Phase 4 Completed
NCT01099423 2017-02-08
SURTIME
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Unknown
NCT01553175 2016-07-14
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
Children's Oncology Group
Completed
NCT01353300 2016-07-11
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Children's Oncology Group
Completed
NCT01542333 2016-05-18
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Completed
NCT01544569 2016-05-18
Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors
Children's Oncology Group
Completed
NCT01576211 2016-05-18
Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Completed
NCT00747305 2015-10-22
Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
Medical University of South Carolina
Phase 1 Terminated
NCT00908739 2015-09-30
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
Case Comprehensive Cancer Center
Withdrawn
NCT00589550 2015-06-08
PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
Ohio State University Comprehensive Cancer Center
Phase 1 Terminated
NCT01004783 2015-05-07
Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
Children's Oncology Group
Completed
NCT00717587 2014-01-10
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00492440 2012-10-18
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer
Cytheris SA
Phase 1 Terminated
NCT00323791 2009-12-11
Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
Rutgers, The State University of New Jersey
Phase 2 Terminated